Here are four things to know:
1. The company expects to generate 5.5 percent to 6 percent of sales on operation basis in the third quarter of 2017.
2. Johnson & Johnson’s recent expandable cage launch is expected to add the company’s sales in the third quarter.
3. During the second quarter of 2017, Johnson & Johnson acquired Abbott Medical Optics for $4.3 billion, helping to drive sales growth. The company reported around $25 million in sales through acquired business lines for the second quarter.
4. Johnson & Johnson registered $18.8 billion in revenues in the second quarter of 2017, up around 1.6 percent year-over-year.
More articles on devices and implants:
How NICO’s BrainPath Approach & technology is ‘revolutionizing’ neurosurgery
NuVasive, Alphatec, Medtronic & more: 17 device company notes
Stryker receives $3.4M tax rebate to expand in Utah: 5 observations
